The investor presentation “MagSense® Technology: Early Detection of Cancer Through Targeted Imaging” has been announced and is available for download here.
Download the non-deal roadshow presentation MagSense Technology.
Imagion MagSense Breast Cancer Program Phase 2 Clinical Trial Update
July 15, 2025
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging